650 related articles for article (PubMed ID: 11044365)
1. Bcl-2/Bax protein ratio predicts 5-fluorouracil sensitivity independently of p53 status.
Mirjolet JF; Barberi-Heyob M; Didelot C; Peyrat JP; Abecassis J; Millon R; Merlin JL
Br J Cancer; 2000 Nov; 83(10):1380-6. PubMed ID: 11044365
[TBL] [Abstract][Full Text] [Related]
2. p53 apoptotic response to DNA damage dependent on bcl2 but not bax in head and neck squamous cell carcinoma lines.
Crowe DL; Sinha UK
Head Neck; 2006 Jan; 28(1):15-23. PubMed ID: 16302195
[TBL] [Abstract][Full Text] [Related]
3. Association between cisplatin resistance and mutation of p53 gene and reduced bax expression in ovarian carcinoma cell systems.
Perego P; Giarola M; Righetti SC; Supino R; Caserini C; Delia D; Pierotti MA; Miyashita T; Reed JC; Zunino F
Cancer Res; 1996 Feb; 56(3):556-62. PubMed ID: 8564971
[TBL] [Abstract][Full Text] [Related]
4. Role of p53 in G2/M cell cycle arrest and apoptosis in response to gamma-irradiation in ovarian carcinoma cell lines.
Concin N; Stimpfl M; Zeillinger C; Wolff U; Hefler L; Sedlak J; Leodolter S; Zeillinger R
Int J Oncol; 2003 Jan; 22(1):51-7. PubMed ID: 12469184
[TBL] [Abstract][Full Text] [Related]
5. p53 independent G0/G1 arrest and apoptosis induced by a novel retinoid in human breast cancer cells.
Shao ZM; Dawson MI; Li XS; Rishi AK; Sheikh MS; Han QX; Ordonez JV; Shroot B; Fontana JA
Oncogene; 1995 Aug; 11(3):493-504. PubMed ID: 7630633
[TBL] [Abstract][Full Text] [Related]
6. p53 status does not affect sensitivity of human ovarian cancer cell lines to paclitaxel.
Debernardis D; Siré EG; De Feudis P; Vikhanskaya F; Valenti M; Russo P; Parodi S; D'Incalci M; Broggini M
Cancer Res; 1997 Mar; 57(5):870-4. PubMed ID: 9041188
[TBL] [Abstract][Full Text] [Related]
7. p53 mutations and p53, Waf-1, Bax and Bcl-2 expression in field cancerization of the head and neck.
Lavieille JP; Gazzeri S; Riva C; Reyt E; Brambilla C; Brambilla E
Anticancer Res; 1998; 18(6B):4741-9. PubMed ID: 9891551
[TBL] [Abstract][Full Text] [Related]
8. The role of thymidylate synthase induction in modulating p53-regulated gene expression in response to 5-fluorouracil and antifolates.
Longley DB; Boyer J; Allen WL; Latif T; Ferguson PR; Maxwell PJ; McDermott U; Lynch M; Harkin DP; Johnston PG
Cancer Res; 2002 May; 62(9):2644-9. PubMed ID: 11980662
[TBL] [Abstract][Full Text] [Related]
9. Tamoxifen-induced apoptosis in breast cancer cells relates to down-regulation of bcl-2, but not bax and bcl-X(L), without alteration of p53 protein levels.
Zhang GJ; Kimijima I; Onda M; Kanno M; Sato H; Watanabe T; Tsuchiya A; Abe R; Takenoshita S
Clin Cancer Res; 1999 Oct; 5(10):2971-7. PubMed ID: 10537367
[TBL] [Abstract][Full Text] [Related]
10. Expression of apoptosis-related genes in human head and neck squamous cell carcinomas undergoing p53-mediated programmed cell death.
Frederick MJ; Holton PR; Hudson M; Wang M; Clayman GL
Clin Cancer Res; 1999 Feb; 5(2):361-9. PubMed ID: 10037186
[TBL] [Abstract][Full Text] [Related]
11. Mutation of p53 in head and neck squamous cell carcinoma correlates with Bcl-2 expression and increased susceptibility to cisplatin-induced apoptosis.
Andrews GA; Xi S; Pomerantz RG; Lin CJ; Gooding WE; Wentzel AL; Wu L; Sidransky D; Grandis JR
Head Neck; 2004 Oct; 26(10):870-7. PubMed ID: 15390206
[TBL] [Abstract][Full Text] [Related]
12. Expression of apoptosis and cell cycle related genes in proliferating and colcemid arrested cells of divergent lineage.
Gallaher BW; Berthold A; Klammt J; Knüpfer M; Kratzsch J; Bartsch M; Kiess W
Cell Mol Biol (Noisy-le-grand); 2000 Feb; 46(1):79-88. PubMed ID: 10726974
[TBL] [Abstract][Full Text] [Related]
13. Alteration of the Bcl-2/Bax status of head and neck cancer cell lines by chemotherapeutic agents.
Kawakami K; Tsukuda M; Mizuno H; Nishimura G; Ishii A; Hamajima K
Anticancer Res; 1999; 19(5B):3927-32. PubMed ID: 10628333
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of apoptosis induced by the synthetic retinoid CD437 in human non-small cell lung carcinoma cells.
Sun SY; Yue P; Wu GS; El-Deiry WS; Shroot B; Hong WK; Lotan R
Oncogene; 1999 Apr; 18(14):2357-65. PubMed ID: 10327056
[TBL] [Abstract][Full Text] [Related]
15. Dual antitumor effects of 5-fluorouracil on the cell cycle in colorectal carcinoma cells: a novel target mechanism concept for pharmacokinetic modulating chemotherapy.
Yoshikawa R; Kusunoki M; Yanagi H; Noda M; Furuyama JI; Yamamura T; Hashimoto-Tamaoki T
Cancer Res; 2001 Feb; 61(3):1029-37. PubMed ID: 11221829
[TBL] [Abstract][Full Text] [Related]
16. Normal p53 status and function despite the development of drug resistance in human breast cancer cells.
Wosikowski K; Regis JT; Robey RW; Alvarez M; Buters JT; Gudas JM; Bates SE
Cell Growth Differ; 1995 Nov; 6(11):1395-403. PubMed ID: 8562478
[TBL] [Abstract][Full Text] [Related]
17. An informatics approach identifying markers of chemosensitivity in human cancer cell lines.
Amundson SA; Myers TG; Scudiero D; Kitada S; Reed JC; Fornace AJ
Cancer Res; 2000 Nov; 60(21):6101-10. PubMed ID: 11085534
[TBL] [Abstract][Full Text] [Related]
18. p21 promotes ceramide-induced apoptosis and antagonizes the antideath effect of Bcl-2 in human hepatocarcinoma cells.
Kang KH; Kim WH; Choi KH
Exp Cell Res; 1999 Dec; 253(2):403-12. PubMed ID: 10585263
[TBL] [Abstract][Full Text] [Related]
19. Mutant p53 mediated induction of cell cycle arrest and apoptosis at G1 phase by 9-hydroxyellipticine.
Sugikawa E; Hosoi T; Yazaki N; Gamanuma M; Nakanishi N; Ohashi M
Anticancer Res; 1999; 19(4B):3099-108. PubMed ID: 10652599
[TBL] [Abstract][Full Text] [Related]
20. Differential regulation of p53, c-Myc, Bcl-2 and Bax protein expression during apoptosis induced by widely divergent stimuli in human hepatoblastoma cells.
Jiang MC; Yang-Yen HF; Lin JK; Yen JJ
Oncogene; 1996 Aug; 13(3):609-16. PubMed ID: 8760302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
